SCHEMBL4495436

SCHEMBL4495436

COc1ccc(-n2c(N)cc(=O)[nH]c2=S)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.55
ALDH1A1 P00352 5/20 0.52
KMT2A Q03164 4/20 0.52
GAA P10253 1/20 0.51
MAPT P10636 2/20 0.50
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
KDM4E B2RXH2 1/20 0.48
PKM P14618 1/20 0.48
MEN1 O00255 1/20 0.48
CA12 O43570 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
CA1 P00915 1/20 0.47
LMNA P02545 1/20 0.46
PPARG P37231 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
NR2E3 Q9Y5X4 1/20 0.46
NCOR2 Q9Y618 1/20 0.46
ESR2 Q92731 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4465659 0.86 KMT2A (0.43) ATMALDH1A1KMT2AGAAMAPT
SCHEMBL7084232 0.85 ALDH1A1 (0.49) ALDH1A1KMT2AGAAMAPTHPGD
SCHEMBL9381308 0.84 ATM (0.73) ATMALDH1A1KMT2AGAAMAPT
SCHEMBL7255769 0.83 ALDH1A1 (0.60) ALDH1A1KMT2AGAAMAPTHPGD
SCHEMBL7088161 0.80 GAA (0.55) ALDH1A1KMT2AGAAMAPTHPGD
SCHEMBL4500342 0.80 MAPT (0.68) ATMALDH1A1KMT2AGAAMAPT
SCHEMBL4457582 0.77 KMT2A (0.55) ATMALDH1A1KMT2AMAPTHPGD
SCHEMBL1958423 0.76 GAA (0.59) ALDH1A1KMT2AGAAMAPTHPGD
SCHEMBL4498185 0.74 ALDH1A1 (0.68) ALDH1A1KMT2AGAAMAPTHPGD
SCHEMBL4511434 0.73 GAA (0.54) ALDH1A1KMT2AGAAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286813-A1 Thioxanthine Derivatives and Their Use as Inhibitors of MPO ASTRAZENECA AB (SE) 2009-11-19 US disclosed
US-20030232813-A1 Novel amino substituted pyrimidinone derivatives ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2003-12-18 US disclosed
WO-2003084936-A2 AMINO SUBSTITUTED PYRIMIDINONE DERIVATIVES USEFUL IN THE TREATMENT OF INFLAMMATION AND IMMUNOLOGICAL ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2003-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286813-A1 Thioxanthine Derivatives and Their Use as Inhibitors of MPO MPO, XDH, EPX ATM 1511/4885ALDH1A1 296/4885KMT2A 2979/4885
US-20030232813-A1 Novel amino substituted pyrimidinone derivatives TPMT, TYMP, CYP3A5 ATM 2207/4885ALDH1A1 596/4885KMT2A 3187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.